Abstract: Hepatitis B and hepatitis C are among the most
significant hepatic infections all around the world that may lead to
hepatocellular carcinoma. This study is first time performed at the
blood transfussion centre of Omar hospital, Lahore. It aims to
determine the sero-prevalence of these diseases by screening the
apparently healthy blood donors who might be the carriers of HBV or
HCV and pose a high risk in the transmission. It also aims the
comparison between the sensitivity of two diagnostic tests;
chromatographic immunoassay – one step test device and Enzyme
Linked Immuno Sorbant Assay (ELISA). Blood serum of 855
apparently healthy blood donors was screened for Hepatitis B surface
antigen (HBsAg) and for anti HCV antibodies. SPSS version 12.0
and X2 (Chi-square) test were used for statistical analysis. The seroprevalence
of HCV was 8.07% by the device method and by ELISA
9.12% and that of HBV was 5.6% by the device and 6.43% by
ELISA. The unavailability of vaccination against HCV makes it more
prevalent. Comparing the two diagnostic methods, ELISA proved to
be more sensitive.